⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QTTB News
Q32 Bio Inc. Common Stock
Form 8-K
sec.gov
QTTB
Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants
prnewswire.com
QTTB
Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
prnewswire.com
QTTB
Form 8-K
sec.gov
QTTB
Form 8-K
sec.gov
QTTB
Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata
prnewswire.com
QTTB
Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026
prnewswire.com
QTTB
Form 8-K
sec.gov
QTTB
Form 8-K
sec.gov
QTTB
Q32 Bio Announces $55 Million Private Placement Financing
prnewswire.com
QTTB